483
Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. – FDA 483, Aug 1, 2023
Record Details
Zhejiang Jinhua Conba Bio-Pharm Co. Ltd. was inspected and cited for significant deficiencies across its manufacturing operations. The inspection revealed issues with facility separation leading to cross-contamination risks, inadequate employee training for visual inspection, and insufficient laboratory controls including media testing. Additionally, the firm lacked established procedures to prevent microbiological contamination of sterile products.
View Company Profile
ID · 198dd118-429d-4ce8-858c-c5315e01f69e
Other documents for Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.